Innovative Therapies For Children with Cancer Consortium

• The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

  Collaborator, Phase 2, Recruiting, 46 people, 1 May 2026

• NCT05751044

  Collaborator, Phase 1/2, Recruiting, 26 people, 2 Mar 2023

• NCT05745714

  Collaborator, Phase 1/2, Recruiting, 26 people, 27 Feb 2023

• NCT05740449

  Collaborator, Phase 1/2, Withdrawn, 0 people, 23 Feb 2023

• NCT05658640

  Collaborator, Phase 1/2, Recruiting, 26 people, 21 Dec 2022

• NCT05476939

  Collaborator, Phase 3, Recruiting, 433 people, 27 Jul 2022

• NCT03793478

  Collaborator, Phase 1/2, Active, not recruiting, 65 people, 4 Jan 2019

• NCT02303821

  Collaborator, Phase 1, Completed, 141 people, 1 Dec 2014

• NCT02233049

  Collaborator, Phase 2, Status unknown, 250 people, 8 Sept 2014

• NCT00306202

  Collaborator, Phase 1, Completed, 63 people, 23 Mar 2006

Sources: clinicaltrials.gov